pyridine has been researched along with raltegravir potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, TR; Hughes, SH; Maddali, K; Marchand, C; Metifiot, M; Pommier, Y; Smith, SJ; Vu, BC; Zhao, XZ | 1 |
| Burke, TR; Hughes, SH; Johnson, BC; Marchand, C; Métifiot, M; Pommier, Y; Smith, SJ; Zhao, XZ | 1 |
2 other study(ies) available for pyridine and raltegravir potassium
| Article | Year |
|---|---|
Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.
Topics: Amino Acid Substitution; Binding Sites; Bridged Bicyclo Compounds; Cell Line, Tumor; Computer Simulation; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Imides; Mutation; Pyridines; Pyridones; Pyrrolidinones; Raltegravir Potassium | 2012 |
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Integrase; HIV-1; Humans; Magnetic Resonance Spectroscopy; Mutation; Pyridines; Pyrrolidinones; Raltegravir Potassium; Spectrometry, Mass, Electrospray Ionization | 2014 |